{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T01:56:42Z","timestamp":1722909402285},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,7,19]],"date-time":"2009-07-19T00:00:00Z","timestamp":1247961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s11894-009-0042-2","type":"journal-article","created":{"date-parts":[[2009,7,18]],"date-time":"2009-07-18T12:59:19Z","timestamp":1247921959000},"page":"288-294","source":"Crossref","is-referenced-by-count":8,"title":["Managing dyspepsia"],"prefix":"10.1007","volume":"11","author":[{"given":"Alexander C.","family":"Ford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Moayyedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,19]]},"reference":[{"issue":"Suppl1","key":"42_CR1","first-page":"A488","volume":"136","author":"A.C. Ford","year":"2009","unstructured":"Ford AC, Marwaha A, Lim A, et al.: Prevalence of clinically significant endoscopic findings in individuals with and without dyspepsia: systematic review and meta-analysis [abstract]. Gastroenterology 2009, 136(Suppl 1):A488.","journal-title":"Gastroenterology"},{"key":"42_CR2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0140-6736(88)91364-5","volume":"331","author":"D.G. Colin-Jones","year":"1988","unstructured":"Colin-Jones DG, Bloom B, Bodemar G, et al.: Management of dyspepsia: report of a working party. Lancet 1988, 331:576\u2013579.","journal-title":"Lancet"},{"key":"42_CR3","first-page":"145","volume":"4","author":"N.J. Talley","year":"1991","unstructured":"Talley NJ, Colin-Jones DG, Koch KL, et al.: Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterology Intl 1991, 4:145\u2013160.","journal-title":"Gastroenterology Intl"},{"key":"42_CR4","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","volume":"130","author":"J. Tack","year":"2006","unstructured":"Tack J, Talley NJ, Camilleri M, et al.: Functional gastroduodenal disorders. Gastroenterology 2006, 130:1466\u20131479.","journal-title":"Gastroenterology"},{"key":"42_CR5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0016-5085(95)90373-9","volume":"109","author":"L. Agreus","year":"1995","unstructured":"Agreus L, Svardsudd K, Nyren O, et al.: Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995, 109:671\u2013680.","journal-title":"Gastroenterology"},{"key":"42_CR6","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1572-0241.2000.2126_1.x","volume":"95","author":"P. Moayyedi","year":"2000","unstructured":"Moayyedi P, Forman D, Braunholtz D, et al.: The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 2000, 95:1448\u20131455.","journal-title":"Am J Gastroenterol"},{"key":"42_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1572-0241.2000.01735.x","volume":"95","author":"N.A. Koloski","year":"2000","unstructured":"Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000, 95:67\u201371.","journal-title":"Am J Gastroenterol"},{"key":"42_CR8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gut.2006.099846","volume":"56","author":"A.C. Ford","year":"2007","unstructured":"Ford AC, Forman D, Bailey AG, et al.: Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study. Gut 2007, 56:321\u2013327.","journal-title":"Gut"},{"key":"42_CR9","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s10620-006-3112-4","volume":"51","author":"A. Minocha","year":"2006","unstructured":"Minocha A, Chad W, Do W, et al.: Racial differences in epidemiology of irritable bowel syndrome alone, un-investigated dyspepsia alone, and \u201coverlap syndrome\u201d among African Americans compared to Caucasians: a population-based study. Dig Dis Sci 2006, 51:218\u2013226.","journal-title":"Dig Dis Sci"},{"key":"42_CR10","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-2036.2008.03813.x","volume":"28","author":"A.C. Ford","year":"2008","unstructured":"Ford AC, Forman D, Bailey AG, et al.: Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study. Aliment Pharmacol Ther 2008, 28:1013\u20131020.","journal-title":"Aliment Pharmacol Ther"},{"key":"42_CR11","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1572-0241.2007.01080.x","volume":"102","author":"A.C. Ford","year":"2007","unstructured":"Ford AC, Forman D, Bailey AG, et al.: Who consults with dyspepsia? Results from a longitudinal ten-year follow-up study. Am J Gastroenterol 2007, 102:957\u2013965.","journal-title":"Am J Gastroenterol"},{"key":"42_CR12","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/0016-5085(92)90764-P","volume":"102","author":"N.J. Talley","year":"1992","unstructured":"Talley NJ, Zinsmeister AR, Schleck CD, et al.: Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992, 102:1259\u20131268.","journal-title":"Gastroenterology"},{"key":"42_CR13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2036.1996.tb00180.x","volume":"10","author":"J.G. Penston","year":"1996","unstructured":"Penston JG, Pounder RE: A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996, 10:83\u201389.","journal-title":"Aliment Pharmacol Ther"},{"key":"42_CR14","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0002-9343(97)00308-2","volume":"103","author":"T.R. Levin","year":"1997","unstructured":"Levin TR, Schmittdiel JA, Kunz K, et al.: Costs of acid-related disorders to a health maintenance organization. Am J Med 1997, 103:520\u2013528.","journal-title":"Am J Med"},{"issue":"Suppl4","key":"42_CR15","first-page":"10","volume":"50","author":"P. Moayyedi","year":"2002","unstructured":"Moayyedi P, Mason J: Clinical and economic consequences of dyspepsia in the community. Gut 2002, 50(Suppl 4):10\u201312.","journal-title":"Gut"},{"key":"42_CR16","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1053\/j.gastro.2005.09.020","volume":"129","author":"N.J. Talley","year":"2005","unstructured":"Talley NJ, Vakil NB, Moayyedi P: American Gastroenterological Association technical review on the evaluation of dyspepsia. Gastroenterology 2005, 129:1756\u20131780.","journal-title":"Gastroenterology"},{"key":"42_CR17","unstructured":"National Institute for Clinical Excellence: Dyspepsia: managing dyspepsia in adults in primary care. Available at http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG017fullguideline.pdf 2004. Accessed April 2009."},{"key":"42_CR18","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/j.1572-0241.2005.00225.x","volume":"100","author":"N.J. Talley","year":"2005","unstructured":"Talley NJ, Vakil N, Practice Parameters Committee of the American College of Gastroenterology: Guidelines for the management of dyspepsia. Am J Gastroenterol 2005, 100:2324\u20132337.","journal-title":"Am J Gastroenterol"},{"key":"42_CR19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2006.04.029","volume":"131","author":"N. Vakil","year":"2006","unstructured":"Vakil N, Moayyedi P, Fennerty MB, et al.: Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology 2006, 131:390\u2013401.","journal-title":"Gastroenterology"},{"key":"42_CR20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/gut.43.3.327","volume":"43","author":"H. El-Serag","year":"1998","unstructured":"El-Serag H, Sonnenberg A: Opposing time trends of peptic ulcer and reflux disease. Gut 1998, 43:327\u2013333.","journal-title":"Gut"},{"key":"42_CR21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.7326\/0003-4819-120-12-199406150-00001","volume":"120","author":"A. Nomura","year":"1994","unstructured":"Nomura A, Stemmerman GN, Chyou P-H, et al.: Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 1994, 120:977\u2013981.","journal-title":"Ann Intern Med"},{"key":"42_CR22","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/archinte.158.8.852","volume":"158","author":"A. Sonnenberg","year":"1998","unstructured":"Sonnenberg A, Schwartz JS, Cutler AF, et al.: Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Arch Intern Med 1998, 158:852\u2013860.","journal-title":"Arch Intern Med"},{"key":"42_CR23","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/j.1572-0241.2004.40014.x","volume":"99","author":"A.C. Ford","year":"2004","unstructured":"Ford AC, Delaney BC, Forman D, et al.: Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol 2004, 99:1833\u20131855.","journal-title":"Am J Gastroenterol"},{"key":"42_CR24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0016-5085(88)90606-3","volume":"94","author":"E.A.J. Rauws","year":"1988","unstructured":"Rauws EAJ, Langenberg W, Houthoff HJ, et al.: Campylobacter pyloridis-associated chronic active antral gastritis: a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988, 94:33\u201340.","journal-title":"Gastroenterology"},{"key":"42_CR25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-134-5-200103060-00008","volume":"134","author":"L. Laine","year":"2001","unstructured":"Laine L, Schoenfeld P, Fennerty MB: Therapy for Helicobacter pylori in patients with non-ulcer dyspepsia: a meta-analysis of randomized, controlled trials. Ann Intern Med 2001, 134:361\u2013369.","journal-title":"Ann Intern Med"},{"key":"42_CR26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/bmj.321.7262.659","volume":"321","author":"P. Moayyedi","year":"2000","unstructured":"Moayyedi P, Soo S, Deeks JJ, et al.: Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Br Med J 2000, 321:659\u2013664.","journal-title":"Br Med J"},{"key":"42_CR27","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1111\/j.1572-0241.2003.08724.x","volume":"98","author":"P. Moayyedi","year":"2003","unstructured":"Moayyedi P, Deeks J, Talley NJ, et al.: An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in non-ulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 2003, 98:2621\u20132626.","journal-title":"Am J Gastroenterol"},{"key":"42_CR28","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Soo S, Deeks J, et al.: Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006, (2):CD002096.","DOI":"10.1002\/14651858.CD002096.pub4"},{"key":"42_CR29","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Soo S, Deeks J, et al.: Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006, (4):CD001960.","DOI":"10.1002\/14651858.CD001960.pub3"},{"key":"42_CR30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2036.2004.01878.x","volume":"19","author":"N.S. Abraham","year":"2004","unstructured":"Abraham NS, Moayyedi P, Daniels B, et al.: The methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia. Aliment Pharmacol Ther 2004, 19:631\u2013641.","journal-title":"Aliment Pharmacol Ther"},{"key":"42_CR31","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/j.gastro.2004.08.026","volume":"127","author":"P. Moayyedi","year":"2004","unstructured":"Moayyedi P, Delaney BC, Vakil N, et al.: The efficacy of proton pump inhibitors in non-ulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004, 127:1329\u20131337.","journal-title":"Gastroenterology"},{"key":"42_CR32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.2008.163162","volume":"58","author":"A.C. Ford","year":"2009","unstructured":"Ford AC, Talley NJ, Schoenfeld PS, et al.: Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009, 58:367\u2013378.","journal-title":"Gut"},{"key":"42_CR33","doi-asserted-by":"crossref","unstructured":"Soo S, Moayyedi P, Deeks JJ, et al.: Psychological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005, (2):CD002301.","DOI":"10.1002\/14651858.CD002301.pub4"},{"key":"42_CR34","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1001\/archinte.163.13.1606","volume":"163","author":"N.L.A. Arents","year":"2003","unstructured":"Arents NLA, Thijs JC, van Zwet AA, et al.: Approach to treatment of dyspepsia in primary care: a randomized trial comparing \u2018test and treat\u2019 with prompt endoscopy. Arch Intern Med 2003, 163:1606\u20131612.","journal-title":"Arch Intern Med"},{"key":"42_CR35","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(94)92023-0","volume":"343","author":"P. Bytzer","year":"1994","unstructured":"Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB: Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994, 343:811\u2013816.","journal-title":"Lancet"},{"key":"42_CR36","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(00)03308-0","volume":"356","author":"B.C. Delaney","year":"2000","unstructured":"Delaney BC, Wilson S, Roalfe A, et al.: Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care. Lancet 2000, 356:1965\u20131969.","journal-title":"Lancet"},{"key":"42_CR37","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/bmj.322.7291.898","volume":"322","author":"B.C. Delaney","year":"2001","unstructured":"Delaney BC, Wilson S, Roalfe A, et al.: Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care. Br Med J 2001, 322:898\u2013901.","journal-title":"Br Med J"},{"key":"42_CR38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2036.2008.03852.x","volume":"29","author":"A.E. Duggan","year":"2009","unstructured":"Duggan AE, Elliott CA, Miller P, et al.: Clinical trial: a randomized trial of endoscopy, Helicobacter pylori testing and empirical therapy for the management of dyspepsia in primary care. Aliment Pharmacol Ther 2009, 29:55\u201368.","journal-title":"Aliment Pharmacol Ther"},{"key":"42_CR39","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ajg2006227","volume":"101","author":"D.E. Jarbol","year":"2006","unstructured":"Jarbol DE, Kragstrup J, Stovring H, et al.: Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial. Am J Gastroenterol 2006, 101:1200\u20131208.","journal-title":"Am J Gastroenterol"},{"key":"42_CR40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(00)02553-8","volume":"356","author":"A.T. Lassen","year":"2000","unstructured":"Lassen AT, Pedersen FM, Bytzer P, et al.: Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial. Lancet 2000, 356:455\u2013460.","journal-title":"Lancet"},{"key":"42_CR41","first-page":"619","volume":"51","author":"N.T. Lewin van den Broek","year":"2001","unstructured":"Lewin van den Broek NT, Numans ME, Buskens E, et al.: A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome. Br J Gen Pract 2001, 51:619\u2013624.","journal-title":"Br J Gen Pract"},{"key":"42_CR42","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bmj.324.7344.999","volume":"324","author":"K.E.L. McColl","year":"2002","unstructured":"McColl KEL, Murray LS, Gillen D, et al.: Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H. pylori testing alone in the management of dyspepsia. Br Med J 2002, 324:999\u20131002.","journal-title":"Br Med J"},{"key":"42_CR43","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1053\/j.gastro.2005.03.004","volume":"128","author":"A.C. Ford","year":"2005","unstructured":"Ford AC, Qume M, Moayyedi P, et al.: Helicobacter pylori \u201ctest and treat\u201d or endoscopy for managing dyspepsia? An individual patient data meta-analysis. Gastroenterology 2005, 128:1838\u20131844.","journal-title":"Gastroenterology"},{"key":"42_CR44","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2036.2008.03784.x","volume":"28","author":"A.C. Ford","year":"2008","unstructured":"Ford AC, Moayyedi P, Jarbol DE, et al.: Meta-analysis: Helicobacter pylori \u201ctest and treat\u201d compared with empirical acid suppression for managing dyspepsia. Aliment Pharmacol Ther 2008, 28:534\u2013544.","journal-title":"Aliment Pharmacol Ther"},{"key":"42_CR45","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1136\/gut.2004.043570","volume":"53","author":"A.T. Lassen","year":"2004","unstructured":"Lassen AT, Hallas J, Schaffalitzky de Muckadell OB: Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow-up of a randomised controlled trial. Gut 2004, 53:1758\u20131763.","journal-title":"Gut"},{"key":"42_CR46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39479.640486.AE","volume":"336","author":"B.C. Delaney","year":"2008","unstructured":"Delaney BC, Qume M, Moayyedi P, et al.: Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multi-centre randomised controlled trial (MRC-CUBE trial). Br Med J 2008, 336:651\u2013654.","journal-title":"Br Med J"},{"key":"42_CR47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(09)60070-2","volume":"373","author":"C.J. Marrewijk van","year":"2009","unstructured":"van Marrewijk CJ, Mujakovic S, Fransen GAJ, et al.: Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial. Lancet 2009, 373:215\u2013225.","journal-title":"Lancet"},{"key":"42_CR48","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2036.2006.03234.x","volume":"25","author":"A.S. Raghunath","year":"2007","unstructured":"Raghunath AS, Hungin AP, Mason J, et al.: Helicobacter pylori eradication in long-term proton pump inhibitor users in primary care: a randomized controlled trial. Aliment Pharmacol Ther 2007, 25:585\u2013592.","journal-title":"Aliment Pharmacol Ther"},{"key":"42_CR49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.49.3.347","volume":"49","author":"HelicobacterCancer Collaborative Group","year":"2001","unstructured":"Helicobacter and Cancer Collaborative Group: Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001, 49:347\u2013353.","journal-title":"Gut"},{"key":"42_CR50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.38702.662546.55","volume":"332","author":"J.A. Lane","year":"2006","unstructured":"Lane JA, Murray LJ, Noble S, et al.: Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol Helicobacter project: randomised controlled trial. Br Med J 2006, 332:199\u2013202.","journal-title":"Br Med J"},{"key":"42_CR51","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(00)02236-4","volume":"355","author":"P. Moayyedi","year":"2000","unstructured":"Moayyedi P, Feltbower R, Brown J, et al.: Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 2000, 355:1665\u20131669.","journal-title":"Lancet"},{"key":"42_CR52","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1365-2036.2002.01204.x","volume":"16","author":"J. Mason","year":"2002","unstructured":"Mason J, Axon ATR, Forman D, et al.: The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomised controlled trial. Aliment Pharmacol Ther 2002, 16:559\u2013568.","journal-title":"Aliment Pharmacol Ther"},{"key":"42_CR53","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1053\/j.gastro.2005.09.016","volume":"129","author":"A.C. Ford","year":"2005","unstructured":"Ford AC, Forman D, Bailey AG, et al.: A community screening program for Helicobacter pylori saves money: ten-year follow-up of a randomised controlled trial. Gastroenterology 2005, 129:1910\u20131917.","journal-title":"Gastroenterology"},{"key":"42_CR54","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1572-0241.2008.01819.x","volume":"103","author":"N.J. Talley","year":"2008","unstructured":"Talley NJ, Fock KM, Moayyedi P: Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008, 103:510\u2013514.","journal-title":"Am J Gastroenterol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-009-0042-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-009-0042-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-009-0042-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:04:05Z","timestamp":1559433845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-009-0042-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,19]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["42"],"URL":"https:\/\/doi.org\/10.1007\/s11894-009-0042-2","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,19]]}}}